Paracelsus Derivative litigation was a shareholder derivative action arising out of the merger of a publicly held hospital company with and into a firm in the same industry that had been privately held.  After defeating motions to dismiss on various grounds, conducting discovery, and engaging in mediations, Plaintiffs recovered over $18 million in benefits on behalf of the successor company from various insiders of both companies involved.